BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25210633)

  • 1. Hydralazine induces myeloperoxidase and proteinase 3 anti-neutrophil cytoplasmic antibody vasculitis and leads to pulmonary renal syndrome.
    Agarwal G; Sultan G; Werner SL; Hura C
    Case Rep Nephrol; 2014; 2014():868590. PubMed ID: 25210633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydralazine-Induced ANCA Vasculitis in the Setting of Acute Clostridium Difficile Infection.
    Rasla S; El Meligy A; Cucu DF
    R I Med J (2013); 2016 Nov; 99(11):41-43. PubMed ID: 27801920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis After 10 Years of Hydralazine Use.
    Russe-Russe JR; Pellegrini JR; Alvarez-Betancourt A; Munshi RF; Anand P
    Cureus; 2021 Oct; 13(10):e18974. PubMed ID: 34820229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage.
    Xue A; Bernard A; Moreno V; Phillips L; Raff E
    Cureus; 2023 Oct; 15(10):e47591. PubMed ID: 38022102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.
    Dobre M; Wish J; Negrea L
    Ren Fail; 2009; 31(8):745-8. PubMed ID: 19814644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydralazine-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Asymptomatic and Renal-Restricted Presentation.
    Tu W; Fayman B; Ward SC; Mamoon Y; Bandagi SS
    Am J Case Rep; 2021 May; 22():e931263. PubMed ID: 33993184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A challenging twist in pulmonary renal syndrome.
    Namas R; Rubin B; Adwar W; Meysami A
    Case Rep Rheumatol; 2014; 2014():516362. PubMed ID: 25525550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis Secondary to Hydralazine: A Case Report.
    Abdullah A; Anwar MS; Ijaz M; Karim MS; Rosen R; Bokhari SRA
    Cureus; 2022 Dec; 14(12):e32603. PubMed ID: 36654641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report.
    Keasberry J; Frazier J; Isbel NM; Van Eps CL; Oliver K; Mudge DW
    J Med Case Rep; 2013 Jan; 7():20. PubMed ID: 23316942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report.
    Al-Abdouh A; Siyal AM; Seid H; Bekele A; Garcia P
    J Med Case Rep; 2020 Apr; 14(1):47. PubMed ID: 32290867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine.
    Santoriello D; Bomback AS; Kudose S; Batal I; Stokes MB; Canetta PA; Radhakrishnan J; Appel GB; D'Agati VD; Markowitz GS
    Kidney Int; 2021 Aug; 100(2):440-446. PubMed ID: 33857570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping drug-induced vasculitis, ANCA-associated vasculitis, and lupus nephritis caused by low-dose hydralazine.
    Bhatnagar M; Agaronov A; Sarkisyan E; Sotoudeh Deilamy I; Pepito D; Akhondi H
    Int J Rheum Dis; 2023 Nov; 26(11):2272-2277. PubMed ID: 37452463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report.
    Galante JR; Daruwalla CP; Roberts ISD; Haynes R; Storey BC; Bottomley MJ
    BMC Nephrol; 2020 Jul; 21(1):295. PubMed ID: 32703233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis.
    Kumar B; Strouse J; Swee M; Lenert P; Suneja M
    Semin Arthritis Rheum; 2018 Oct; 48(2):283-287. PubMed ID: 29519741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
    Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
    Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.
    Marina VP; Malhotra D; Kaw D
    Int Urol Nephrol; 2012 Dec; 44(6):1907-9. PubMed ID: 21590349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydralazine-Induced Vasculitis.
    Gandhi P; Khurana B; Munjal RS; Sekar A; Gandhi RG
    Cureus; 2023 Feb; 15(2):e35306. PubMed ID: 36994251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal pulmonary-renal syndrome manifested with immune complex crescentic glomerulonephritis in a patient with MPO-ANCA seropositivity.
    Song JH; Lee KJ; Lee SW; Han JY; Kim MJ
    Yonsei Med J; 2001 Aug; 42(4):425-30. PubMed ID: 11519085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.